Key market opportunities in the antibody optimization service industry include addressing rising chronic and complex diseases ...

In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...

Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

Monoclonal antibodies (mAbs) have become a prominent class of drugs during the last decade. In fact, the global therapeutic antibody market is expected to be worth $179.56 billion by 2025. 1 However, ...

Mapping the individual amino acids where antibodies bind (epitopes) to target viral proteins (antigens) is crucial to predicting how target proteins may evolve to escape antibody binding, improve ...

PORTO, Portugal & CAMBRIDGE, England--(BUSINESS WIRE)--FairJourney Biologics and Iontas today announce a partnership to expedite the identification of effective antibodies for a therapeutic to treat ...

Vaishali Verma (left) is an Assistant Professor in the Department of Biotechnology at Bennett University (Uttar Pradesh, India) who develops immunochemical reagents for the diagnosis of drug-resistant ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

The history of antibody engineering and production in drug discovery can be traced back to the 1970s and 1980s [1] when scientists first began to explore the potential of using antibodies as ...